Product Categories
| Country: | China |
|---|---|
| Tel: | 0316-2883536 |
| Mobile: | +8619333636468 |
| E-mail: | 573487203@qq.com |
| QQ: | 2885506126 |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Promestriene | C22H32O2 | 39219-28-8 | Details |
| Nandrolone Impurity 1；Nandrolone acetate | C20H28O3 | 1425-10-1 | Details |
| Nandrolone；Nandrolone Decanoate EP Impurity D | C18H26O2 | 434-22-0 | Details |
| Cabozantinib impurity 1 | C17H16N2O3 | 748707-58-6 | Details |
| 1,1-Cyclobutanedicarboxylic acid | C6H8O4 | 5445-51-2 | Details |
| Cyclobutanecarboxylic acid, 1-[[(4-fluorophenyl)amino]carbonyl]- | C12H12FNO3 | 849217-49-8 | Details |
| Cabozantinib Impurity 11 | C18H18N2O2 | 861345-47-3 | Details |
| 6-Chloro-1-hydroxibenzotriazol | C6H4ClN3O | 26198-19-6 | Details |
| Cabozantinib Impurity 10 | C39H34N4O8 | 2439164-91-5 | Details |
| Cabozantinib Impurity | C17H14N2O5 | 190728-26-8 | Details |
| Cabozantinib Impurity 9 | C17H14F2N2O2 | 1431468-36-8 | Details |
| 4-[(E)-(4-hydroxyphenyl)azo]phenol | C12H10N2O2 | 2050-16-0 | Details |
| Cabozantinib Impurity 42 | C9H8FNO3 | 95262-10-5 | Details |
| Cabozantinib impurity | C17H14Cl2N2O2 | 1904529-45-8 | Details |
| Cabozantinib impurity 47 | C11H10ClNO3 | 113136-79-1 | Details |
| Formamide, N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]- | C18H16N2O4 | 190728-28-0 | Details |
| N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-N-phenylcyclopropane-1,1-dicarboxamide | C28H25N3O5 | 849221-94-9 | Details |
| Cabozantinib Impurity 6 | C28H24FN3O6 | 1621681-63-7 | Details |
| N1,N3-bis(4-fluorophenyl)malonamide(CabozantinibImpurity） | C15H12F2N2O2 | 1677-29-8 | Details |
| 3-(4-Methyl-piperazin-1-ylmethyl)-benzoic acid | C13H18N2O2 | 514209-42-8 | Details |
| 4-chloromethyl-N-[4-methyl-3-[[4-(1-oxido-3-pyridinyl)-2-pyrimidinyl]-amino]-phenyl]-benzamide | C24H20ClN5O2 | 571187-02-5 | Details |
| Imatinib Impurity 30 | C42H47N9O2 | 1356565-46-2 | Details |
| Imatinib Impurity 31 | C20H26N4O | 581076-63-3 | Details |
| Imatinib Impurity 32 | C20H24N4O3 | 581076-60-0 | Details |
| 6-Chloro-1H-cinnolin-4-one | C8H5ClN2O | 876-89-1 | Details |
| Cabozantinib Impurity 32 | C17H16N2O3 | 202917-04-2 | Details |
| Cabozantinib Impurity 25 | C11H10FNO3 | 1247859-37-5 | Details |
| Imatinib Impurity | C24H19Cl2N5O | Details |
| Imatinib Impurity | C13H17ClN2O | 909342-95-6 | Details |
| Benzoic acid, 4,4'-[1,4-piperazinediylbis(methylene)]bis-, dimethyl ester (9CI) | C22H26N2O4 | 80276-39-7 | Details |
| Imatinib EP Impurity F | C16H15N5 | 152460-10-1 | Details |
| C28H25ClFN3O5 | 2840522-80-5 | Details |
| Diethyl 2-(2-chloroethyl)propanedioate | C9H15ClO4 | 18719-42-1 | Details |
| 1-((4-Fluorophenyl)carbamoyl)cyclopropanecarboxylicacid | C11H10FNO3 | 849217-48-7 | Details |
| Cabozantinib | C28H24FN3O5 | 849217-68-1 | Details |
| Cabozantinib impurity 51 | C10H10FNO | 2354-89-4 | Details |
| Cabozantinib Impurity | C17H14N2O5 | 202917-05-3 | Details |
| Quinoline, 6,7-dimethoxy-4-(4-nitrophenoxy)- | C17H14N2O5 | 190728-24-6 | Details |
| Cabozantinib Impurity4 | C11H15NO3 | 95932-39-1 | Details |
| 1-((4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)carbamoyl)cyclopropane-1-carboxylic acid | C22H20N2O6 | 849217-77-2 | Details |
| Cabozantinib Impurity 14 | C12H13NO3 | 1175127-32-8 | Details |
| Imatinib EP Impurity J | C29H31N7O2 | 571186-91-9 | Details |
| Imatinib EP Impurity C | C21H26ClN2O4+ | 1407124-77-9 | Details |
| Tert-butyl4-(4-(methoxycarbonyl)benzyl)piperazine-1-carboxylate | C18H26N2O4 | 844891-11-8 | Details |
| Imatinib Impurity 17 | C20H22N2O4 | 1802325-93-4 | Details |
| Imatinib Impurity 19 | C7H7NO2 | 14188-94-4 | Details |
| iMatinib related substance C | C29H31N7O2 | 938082-57-6 | Details |
| Imatinib Impurity 11 | C24H20ClN5O | 404844-11-7 | Details |
| 4-(4-Carboxybenzyl)piperazine-1-carboxylic acid tert-butyl ester | C17H24N2O4 | 479353-63-4 | Details |
| N-Desmethyl Imatinib | C28H29N7O | 404844-02-6 | Details |
| Imatinib Impurity 7 | C29H31N7O | 1025975-77-2 | Details |
| Exemestane Impurity 1 | C20H24O2 | 2467590-81-2 | Details |
| Ergostenol Impurity 2；α-Ergostenol | C28H48O | 632-32-6 | Details |
| 16-Dehydropregnenolone acetate Impurity 2；Diosgenin | C27H42O3 | 512-04-9 | Details |
| C9H6ClNO2 | 1256637-72-5 | Details |
| 1-(phenylaminocarbonyl)cyclopropanecarboxylicacid | C11H11NO3 | 145591-80-6 | Details |
| Cabozantinib Impurity 5 | C11H10ClNO3 | 2377278-36-7 | Details |
| Exemestane EP Impurity J | C22H28O3 | 1160599-91-6 | Details |
| Exemestane EP Impurity C | C21H24O2 | 2130745-60-5 | Details |
| Exemestane EP Impurity B | C20H26O3 | 184972-09-6 | Details |
| Benzamide, 4-[[4-[4-[(4-methyl-1-piperazinyl)methyl]benzoyl]-1-piperazinyl]methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]- | C41H45N9O2 | 2410195-23-0 | Details |
| iMatinib related substance B | C29H31N7O3 | 571186-93-1 | Details |
| 3-Dimethylamino-1-(N-oxido-4-pyridyl)-2-propen-1-on | C10H12N2O2 | 2387475-37-6 | Details |
| 1,4-Bis-[4-[4-Methyl-3-[[4-(pyridin-3-yl)pyriMidin-2-yl]aMino]phenyl]carbaMoyl]benzylpiperazine | C52H48N12O2 | 1365802-18-1 | Details |
| Cabozantinib Impurity 8 | C11H10FNO3 | 918642-61-2 | Details |
| N-(4-Fluorophenyl)-N'-(4-hydroxyphenyl)cyclopropane-1,1-dicarboxamide(CabozantinibImpurity) | C17H15FN2O3 | 849217-60-3 | Details |
| Imatinib Impurity 36 | C16H15N5 | 1026194-04-6 | Details |
| Imatinib EP Impurity D | C53H51N12O2+ | 1821122-73-9 | Details |
| Imatinib Impurity 36 | C12H22N2O4S | 322474-21-5 | Details |
| Imatinib EP Impurity B | C21H28N6O | 581076-65-5 | Details |
| Imatinib Impurity 34 | C33H37N7O3 | 1076199-23-9 | Details |
| Imatinib Impurity 33 | C29H31N7O2 | 571186-92-0 | Details |
| vildagliptin Impurity J | C7H9ClN2O | 207557-35-5 | Details |
| Diazene, bis(4-fluorophenyl)-, (Z)- (9CI) | C12H8F2N2 | 51789-00-5 | Details |
| Imatinib Impurity | C13H17ClN2O | 1181636-34-9 | Details |
| vildagliptin Impurity Q | C7H10Cl2N2O2 | 1803168-08-2 | Details |
| vildagliptin Impurity I | C7H11ClN2O2 | 214398-99-9 | Details |
| (R)-1-(2-chloroacetyl)pyrrolidine-2-carboxaMide | C7H11ClN2O2 | 1211679-98-9 | Details |
| vildagliptin Impurity R | C7H8Cl2N2O | 1803168-09-3 | Details |
| Vildagliptin Impurity 53 | C7H10N2O | 700376-84-7 | Details |
| Vildagliptin Impurity 25 | C7H10N2O2 | 1563006-28-9 | Details |
| Vildagliptin Related Compound F | C17H24N2O3 | 1789703-36-1 | Details |
| Vildagliptin Impurity 42 | C5H9ClN2 | 65732-69-6 | Details |
| Vildagliptin IMpurity 2 (Mixture of DiastereoMers) | C24H33N5O3 | 1036959-23-5 | Details |
| Acetamide, N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]- | C19H18N2O4 | 651054-52-3 | Details |
| 4-((6,7-Dimethoxyquinolin-4-yl)oxy)aniline | C17H16N2O3 | 190728-25-7 | Details |
| Cabozantinib impurity | C10H13NO3 | 134611-49-7 | Details |
| (S)-1-N-CBZ-2-CYANO-PYRROLIDINE | C13H14N2O2 | 63808-36-6 | Details |
| Cabozantinib Impurity | C11H9F2NO3 | 1275738-77-6 | Details |
| (2S)-1-(2-chloroacetyl)-N,N-dimethylpyrrolidine-2-carboxamide | C9H15ClN2O2 | 2381862-94-6 | Details |
| Cabozantinib impurity | C11H11NO4 | 2105956-20-3 | Details |
| D-ProlinaMide | C5H10N2O | 62937-45-5 | Details |
| Vildagliptin Chloroacetyl Nitrile (R)-Isomer | C7H9ClN2O | 565452-98-4 | Details |
| Cabozantinib impurity | C12H13NO4 | 918642-60-1 | Details |
| C12H18N4O2 | 2253194-12-4 | Details |
| Cabozantinib impurity | C17H16N2O4 | 2439164-93-7 | Details |
| Vildagliptin Related Compound H | C12H16N4O | 2253194-13-5 | Details |
| vildagliptin Impurity E | C17H25N3O2 | 1789703-37-2 | Details |
| Vildagliptin Impurity 57 | C7H12ClN3O | 913980-23-1 | Details |
| Cabozantinib Impurity 31 | C17H16N2O3 | 190728-27-9 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 | ||||